Related Experiment Video
Updated: May 8, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
A new system to measure and compare hepatitis C virus replication capacity using full-length, replication competent
Britta Lassmann1, Vaithilingaraja Arumugaswami, Kara W Chew
1Division of Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Journal of Virological Methods
|August 27, 2013
Summary
This study introduces a new RT-qPCR method to measure hepatitis C virus (HCV) replication. This assay accurately compares whole genome HCV variants, aiding drug resistance and immune escape mutation research.
Area of Science:
- Virology
- Molecular Biology
- Infectious Diseases
Background:
- Assessing viral replication capacity is crucial for understanding immune pressure and drug efficacy.
- Current methods for measuring hepatitis C virus (HCV) replication, often using sub-genomic reporter constructs, have limitations.
- A need exists for a method to directly compare whole genome viral replication under controlled conditions.
Purpose of the Study:
- To develop and validate a quantitative reverse transcriptase PCR (RT-qPCR) assay for simultaneous measurement of two whole genome HCV variants.
- To enable direct comparison of HCV replication capacities under identical culture conditions.
- To assess the impact of mutations, including drug resistance and immune escape variants, on HCV replication.
Main Methods:
- A novel RT-qPCR assay was designed to simultaneously detect and quantify two distinct whole genome HCV variants.
- Unique sequence tags were incorporated into viral constructs for specific probe-based discrimination.
- Assay specificity, linear detection range, and performance were validated using known HCV mutants, including drug resistance variants (R155K, T54A).
Main Results:
- The RT-qPCR assay demonstrated 100% specificity in detecting each HCV variant.
- A linear detection range from 200 to 2x10^8 copies was established.
- The system successfully discriminated between parental and modified HCV clones, enabling comparative replication analysis.
Conclusions:
- The developed RT-qPCR system offers a sensitive and specific method for comparing the replication capacity of whole genome HCV variants.
- This approach overcomes limitations of previous methods by allowing direct comparison under identical conditions and assessing effects across the entire viral life cycle.
- The assay is valuable for studying the impact of mutations on HCV replication, including those conferring drug resistance or immune evasion.
